Skip to content

Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis

Evaluation of Monocyte Volume Width Distribution (MDW) for Early Detection of Sepsis or Developing Sepsis on the UniCell DxH800 Hematology Analyzer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03145428
Acronym
MDW
Enrollment
3000
Registered
2017-05-09
Start date
2017-06-19
Completion date
2018-01-26
Last updated
2019-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Severe Infection

Brief summary

The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinical performance of MDW for detection of sepsis in the ED.

Detailed description

A prospective multi-center study to establish the clinical utility of the measurement of monocyte volume width distribution, a cell population parameter of the CBC-Differential, on the Beckman Coulter Unicel DxH analyzers. The study will validate the cut-off for the early detection of sepsis in an adult emergency room population where the standard of care included a CBC with Differential and will evaluate the diagnostic performance of the parameter.

Interventions

MDW measurement used to detect sepsis. Results will not be used to manage patients

Sponsors

Beckman Coulter, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults (18-89 years) presenting to ED * All races & ethnicities * CBC with Differential performed upon presentation * Subjects with at least 12 hours of follow-up in ED (or in-patient if admitted)

Exclusion criteria

* Previously enrolled * Subjects discharged \<12 hours form ED presentation

Design outcomes

Primary

MeasureTime frameDescription
Identification of sepsis vs. non-sepsis, including SIRS and infection (non-SIRS) by adjudication based on the 2001 SCCM sepsis definition (sepsis-2)12 hours after presentation to the EDDetermination of the diagnostic accuracy, area under the receiver operating characteristic curve

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026